In this regard, the PIONEER-HF trial, a double-blind, randomized, multicenter study, compared sacubitril/valsartan and enalapril in a population of 882 patients hospitalized for an episode of heart failure and with elevated levels of NT-proBNP. This evidence concerns the gene NPPB and hydrops fetalis.